English German

Pipeline and therapeutic focus

CytoTools’ diverse product pipeline comprises proprietary small molecules and biologics which have the potential to provide new treatment options in dermatology, cardiology and angiology, urology and oncology. More

Lead clinical product - DermaPro®

Our main product DermaPro® has received market approval in India in March 2017. It has demonstrated rapid and effective wound healing in patients with diabetic foot during Phase III clinical trials. Phase III clinical trials in Europe for venous leg ulcer and diabetic foot ulcer must be repeated. More

Ad hoc News/Latest News

09/05/2017

CytoTools withdraws planned convertible bond

25/04/2017

Capital increase

25/04/2017

Ad hoc Capital increase